The current status of hypertensive patients and medicine use at the geriatric - cardiology department - Tue Tinh hospital in 2023

Pham Thuy Phuong1,, Hoang Trong Quan1, Vũ Minh Hieu1, Nguyễn Phạm Ngọc Mai2
1 Viet Nam University of Traditional Medicine & Pharmacy
2 University of Science and Technology of Hanoi

Nội dung chính của bài viết

Tóm tắt

Objective: To survey on the current status of hypertensive patients and the use of medicine to treat hypertension at the Geriatric - Cardiology Department - Tue Tinh Hospital.


Research subjects and methods: A cross-sectional, retrospective and analysis conducted research was conducted on 389 medical records diagnosed with hypertension for outpatient and inpatient treatment at the Department of Geriatrics - Cardiology - Tue Tinh Hospital from January 2023 to the end of December 2023.


Results: In the 389 researched medical records, the mean patient age was 77.8 ± 6.5 years, with the 70–79 age group accounting for the highest proportion (43%) and those under 50 the lowest (4%). Female patients comprised 62%, higher than males (38%), and 78% had age-related risk factors. Five main classes of antihypertensive drugs were used-Angiotensin-Converting Enzyme inhibitors (ACEi), Angiotensin II Receptor Blockers (ARBs), calcium channel blockers (CCB), beta-blockers (BB), and diuretics—all consistent with national treatment guidelines. Monotherapy was more commonly prescribed than combination therapy in both initial (59.1%) and final regimens (52.7%). The rate of achieving target blood pressure was high (88%), approximately seven times greater than the failure rate (12%).


Conclusions: The research sample had an average age of 77.8 ± 65.4 years, mainly from 70-79 years old (43%). The rate of women is 1.5 times higher than that of men. Study of 389 records with 5 groups of antihypertensive drugs. In both therapies, the rate of use of monotherapy regimens was higher than the rate of use of multitherapy regimens. Combinations of 2 to 4 drugs showed different distributions, with beta-blockers being most common in the 3-drug combination group.

Chi tiết bài viết

Tài liệu tham khảo

1. World Health Organization. Hypertension fact sheet, 2023.
2. Ministry of Health Vietnam. National survey on risk factors of non-communicable diseases (STEPS), 2021.
3. Ngo Tri Diem. Analysis of the current status of drug use in the treatment of hypertension at Nghe An General Hospital, Master's thesis in pharmacy, Hanoi University of Pharmacy, Hanoi, 2006, pp.77-78
4. Nguyen Van Tho. Survey on medicine use in the treatment of hypertension at Luong Tai District General Hospital - Bac Ninh, thesis of pharmacist specialist I, Hanoi University of Pharmacy Hanoi, 2012, pp.60-61.
5. The National High Blood Pressure Education Program. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure, NIH Publication, The United States of America, 2003, pp.8-64.
6. Thai Khoa Bao Chau, Vo Thi Hong Nhung. Study on medicine use in the treatment of hypertension at Hue University of Medicine and Pharmacy Hospital. Journal of Medicine and Pharmacy - Hue University of Medicine and Pharmacy, 2015, No. 32.
7. Bryan Williams, Giuseppe Mancia et al. Guidelines for the management of arterial hypertension. European Heart Journal, 2018, Volume 39, Issue 33.
8. Huynh Van Minh, Tran Van Huy et al. Recommendations on diagnosis and treatment of hypertension, Vietnam Cardiology Association - Vietnam Hypertension Association, 2022.